Access to Exclusive Content. FREE for Registered Users Only.
Join the Channelchek Investor Community to access equity research, video content, events, and much more. All at no cost.
Share
Welcome to the Channelchek Investor Community
We’ve updated the entire site to bring you faster navigation and increased content at every level. Channelchek is now North America’s leading platform for access to regulated and independent company sponsored equity research.
By clicking “Log In” you agree to Channelchek.com Terms of Use and acknowledge that Channelchek.com Privacy Policy applies to you.
Related News
9/15/2026
Healthcare
Release – Clinical Trial of the Oral Drug NV-387 to Treat Ebola to Start Next Week, Hoping to Reduce Fatalities and Spread, As the Largest Ebola Outbreak is Expanding in DR Congo with 48% Crude Fatality Rate, Says NanoViricides
NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), a clinical stage leader developing antiviral drugs that viruses cannot escape, announces that its Phase II Clinical Trial of NV-387 Oral Gummies as a...
9/15/2026
Uncategorized
Release – MAIA Biotechnology Announces Open Market Purchases of Company Stock by Long-Standing Board Member and CEO
MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company focused on developing immunotherapies for cancer, today announced that Board member Ramiro Guerrero, JD, LL.M. has increased...
9/15/2026
Aerospace and Defense
Release – V2X Awarded Position on $46 Million U.S. Air Force Contract Supporting B-52 Long Range Standoff Cruise Missile Program
V2X Inc. (NYSE: VVX) has been awarded a position on a $46 million delivery order on the Enterprise-Wide Agile Acquisition Contract Indefinite Delivery/Indefinite Quantity contract supporting the U.S. Air Force’s Carriage...
9/15/2026
Healthcare
GeoVax Labs (GOVX) – GEO-MVA Phase 3 Trial Moves Forward With Laboratory Testing Agreement For Patient Samples
Agreement With CEPI Lab Network Establishes Standardized Sample Testing. GeoVax announced an agreement with CEPI (Coalition for Epidemic Preparedness Innovations) to test patient samples from its Phase 3 GEO-MVA study...
Inbox Intel from Channelchek.
Informed investors make more money. And it’s all about timing. Get it when it happens.
